Long non-coding RNA TUG1 promotes cervical cancer progression by regulating the miR-138-5p-SIRT1 axis. 2017

Jie Zhu, and Huirong Shi, and Huina Liu, and Xiaojuan Wang, and Fengmei Li
Department of Gynecology and Obstetrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.

Increasing evidences showed that long non-coding RNAs (lncRNAs) play vital roles in tumor progression. Recent studies indicated that lncRNA TUG1 was upregulated and promoted tumor processes in several cancers. However, the expression and underlying mechanism of TUG1 in cervical cancer remain unclear. In the present study, we found that TUG1 expression was upregulated in cervical cancer tissues and correlated with advanced clinical features and poor overall survival. TUG1 knockdown suppressed cervical cancer cell growth and metastasis in vitro and tumor growth in vivo. In addition, our results indicated that TUG1 could act as an endogenous sponge by directly binding to miR-138-5p and suppressed miR-138-5p expression. Furthermore, we found that TUG1 could reverse the inhibitory effect of miR-138-5p on cervical cancer cells processes, which might be involved in the activation of SIRT1, a target gene of miR-138-5p, and activation of Wnt/β-catenin signaling pathway. Taken together, we elucidated that TUG1 might promote cervical cancer malignant progression via miR-138-5p-SIRT1-Wnt/β-catenin signaling pathway axis.

UI MeSH Term Description Entries

Related Publications

Jie Zhu, and Huirong Shi, and Huina Liu, and Xiaojuan Wang, and Fengmei Li
January 2020, Cancer cell international,
Jie Zhu, and Huirong Shi, and Huina Liu, and Xiaojuan Wang, and Fengmei Li
April 2020, Human cell,
Jie Zhu, and Huirong Shi, and Huina Liu, and Xiaojuan Wang, and Fengmei Li
October 2022, Cancer biotherapy & radiopharmaceuticals,
Jie Zhu, and Huirong Shi, and Huina Liu, and Xiaojuan Wang, and Fengmei Li
January 2021, Experimental biology and medicine (Maywood, N.J.),
Jie Zhu, and Huirong Shi, and Huina Liu, and Xiaojuan Wang, and Fengmei Li
May 2020, Aging,
Jie Zhu, and Huirong Shi, and Huina Liu, and Xiaojuan Wang, and Fengmei Li
February 2022, Bioengineered,
Jie Zhu, and Huirong Shi, and Huina Liu, and Xiaojuan Wang, and Fengmei Li
October 2021, Experimental eye research,
Jie Zhu, and Huirong Shi, and Huina Liu, and Xiaojuan Wang, and Fengmei Li
June 2020, Bioscience reports,
Jie Zhu, and Huirong Shi, and Huina Liu, and Xiaojuan Wang, and Fengmei Li
June 2022, Cell journal,
Jie Zhu, and Huirong Shi, and Huina Liu, and Xiaojuan Wang, and Fengmei Li
May 2019, Cell cycle (Georgetown, Tex.),
Copied contents to your clipboard!